Compare ELWT & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELWT | INCR |
|---|---|---|
| Founded | 2002 | 1994 |
| Country | United States | Israel |
| Employees | 34 | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.6M | 42.3M |
| IPO Year | N/A | 2021 |
| Metric | ELWT | INCR |
|---|---|---|
| Price | $6.12 | $0.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 39.7K | 22.1K |
| Earning Date | 05-15-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $167.76 | $69.54 |
| Revenue Next Year | $22.42 | $41.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.11 | $0.68 |
| 52 Week High | $8.25 | $1.77 |
| Indicator | ELWT | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 50.22 | 44.88 |
| Support Level | $6.30 | $0.72 |
| Resistance Level | $7.10 | $0.79 |
| Average True Range (ATR) | 0.71 | 0.03 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 58.26 | 57.31 |
Elauwit Connection Inc is a provider of broadband Internet networks for the multifamily and student housing property sector. It designs, installs, operates, and maintains new fiber-optic and WiFi networks throughout each contracted property. Once installed, property owners begin selling Internet connectivity over Elauwit's network directly to their residents at monthly prices and terms of their choosing. Elauwit, in turn, provides all resident activation, onboarding, customer support, and network monitoring and maintenance services in exchange for a fixed monthly fee based on the number of units in the property times a monthly per-unit wholesale price. Its contracts with property owners generally have five to eight-year terms. Geographically, the company mainly operates in the U.S.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.